HIV infection of hepatitis B virus (HBV)-infected hepatocytes increases CXCL10 production and is associated with liver fibrosis in HIV-HBV co-infected individuals

• K.P. Singh,
• J.M. Zerbato,
• W. Zhao,
• S. Braat,
• C. Deleage,
• S. Tennakoon,
• H. Mason,
• A. Rhodes,
• A. Dantanarayana,
• A.N. Harman,
• J. Rhodes,
• J. Torresi,
• P. Revill,
• J. Estes,
• A. Avihingsanon,
• S.R. Lewin,
• J. Audsley

Affiliations

K.P. Singh

Monash University, Central Clinical School at Alfred Health, Melbourne, Australia; Peter Doherty Institute for Infection and Immunity at University of Melbourne, Melbourne, Australia; Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Australia

J.M. Zerbato

Peter Doherty Institute for Infection and Immunity at University of Melbourne, Melbourne, Australia

W. Zhao

Peter Doherty Institute for Infection and Immunity at University of Melbourne, Melbourne, Australia

S. Braat

University of Melbourne, Melbourne School of Population and Global Health and Melbourne Clinical and Translational Sciences Platform (MCATS), Melbourne, Australia

C. Deleage

Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick MD, USA

S. Tennakoon

Peter Doherty Institute for Infection and Immunity at University of Melbourne, Melbourne, Australia

H. Mason

Peter Doherty Institute for Infection and Immunity, Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia

A. Rhodes

Peter Doherty Institute for Infection and Immunity at University of Melbourne, Melbourne, Australia

A. Dantanarayana

Peter Doherty Institute for Infection and Immunity at University of Melbourne, Melbourne, Australia

A.N. Harman

University of Sydney, Westmead Institute for Medical Research, School of Medical Sciences, Faculty of Medicine and Health, Sydney, Australia

J. Rhodes

University of Sydney, Westmead Institute for Medical Research, School of Medical Sciences, Faculty of Medicine and Health, Sydney, Australia

J. Torresi

Peter Doherty Institute for Infection and Immunity at University of Melbourne, Melbourne, Australia

P. Revill

Peter Doherty Institute for Infection and Immunity, Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia

J. Estes

Oregan Health and Science University (OHSU), Vaccine and Gene Therapy Institute, Portland, USA

A. Avihingsanon

Chulalongkorn University, Thai Red Cross AIDS Research Centre and Faculty of Medicine, Bangkok, Thailand

S.R. Lewin

Peter Doherty Institute for Infection and Immunity at University of Melbourne, Melbourne, Australia; Alfred Health and Monash University, Department of Infectious Diseases, Melbourne, Australia

J. Audsley

Peter Doherty Institute for Infection and Immunity at University of Melbourne, Melbourne, Australia